NCT00308685 - Chronic-Dose Safety and Efficacy Study of Albuterol-HFA-BAI in Pediatric Asthmatics | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 10, 2006

Primary Completion Date

December 4, 2006

Study Completion Date

December 4, 2006

Conditions

Asthma

Interventions

DRUG

Albuterol

Albuterol 90mcg

DRUG

Placebo

Trial Locations (14)

31405

Southern Allergy & Asthma, PC, Savannah

44718

Allergy and Respiratory Center, Canton

55402

Clinical Research Institute, Minneapolis

61761

Sneeze, Wheeze & Itch Associates, Inc., Normal

68046

The Asthma & Allergy Center, PC, Papillion

73120

Allergy, Asthma & Clinical Research Center, Oklahoma City

75230

Pediatric Pulmonary Associates of North Texas, Dallas

80112

Colorado Allergy and Asthma Centers, PC, Englewood

80230

Colorado Allergy and Asthma Centers, PC, Denver

80401

Colorado Allergy and Asthma Centers, PC, Lakewood

80907

William Storms Medical Research, Colorado Springs

92647

Allergy & Asthma Specialist Medical Group, Huntington Beach

95117

Allergy & Asthma Associates of Santa Clara Valley Research Center, San Jose

72205-4565

Little Rock Allergy and Asthma, Little Rock

All Listed Sponsors

lead

Teva Branded Pharmaceutical Products R&D, Inc.

INDUSTRY